BIOGEN INC. Other Comprehensive Income (Loss), Net of Tax
BIOGEN INC. (BIIB) reported Other Comprehensive Income (Loss), Net of Tax of $41.80 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-29.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2026-04-29
- BIOGEN INC. other comprehensive income (loss), net of tax for the quarter ending 2026-03-31 was $41.80M.
- BIOGEN INC. other comprehensive income (loss), net of tax for the quarter ending 2025-12-31 was $32.80M, a 245.26% increase year-over-year.
- BIOGEN INC. other comprehensive income (loss), net of tax for the quarter ending 2025-09-30 was $23.30M, a 7666.67% increase year-over-year.
- BIOGEN INC. other comprehensive income (loss), net of tax for the quarter ending 2025-06-30 was -$63.60M, a 538.62% decline year-over-year.
- BIOGEN INC. other comprehensive income (loss), net of tax for fiscal 2025 was -$45.80M, a 361.71% decline from fiscal 2024.
- BIOGEN INC. other comprehensive income (loss), net of tax for fiscal 2024 was $17.50M, a 56.25% increase from fiscal 2023.
- BIOGEN INC. other comprehensive income (loss), net of tax for fiscal 2023 was $11.20M.
- BIOGEN INC. other comprehensive income (loss), net of tax for fiscal 2022 was -$58.20M, a 130.17% decline from fiscal 2021.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 3 month as first filed | Other Comprehensive Income (Loss), Net of Tax 6 month | Other Comprehensive Income (Loss), Net of Tax 6 month as first filed | Other Comprehensive Income (Loss), Net of Tax 9 month | Other Comprehensive Income (Loss), Net of Tax 9 month as first filed | Other Comprehensive Income (Loss), Net of Tax 12 month | Other Comprehensive Income (Loss), Net of Tax 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | $41.80M 10-Q · filed 2026-04-29 | $74.60M derived: sum of 2 quarters · filed 2026-04-29 | $97.90M derived: sum of 3 quarters · filed 2026-04-29 | $34.30M derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2025-12-31 | $32.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | $56.10M derived: sum of 2 quarters · filed 2026-02-06 | -$7.50M derived: sum of 3 quarters · filed 2026-02-06 | -$45.80M 10-K · filed 2026-02-06 | ||||
| 2025-09-30 | $23.30M 10-Q · filed 2025-10-30 | -$40.30M derived: sum of 2 quarters · filed 2025-10-30 | -$78.60M 10-Q · filed 2025-10-30 | -$69.10M derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2025-06-30 | -$63.60M 10-Q · filed 2025-07-31 | -$101.90M 10-Q · filed 2025-07-31 | -$92.40M derived: sum of 3 quarters · filed 2026-04-29 | -$92.10M derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2025-03-31 | -$38.30M 10-Q · filed 2026-04-29 | -$28.80M derived: sum of 2 quarters · filed 2026-04-29 | -$28.50M derived: sum of 3 quarters · filed 2026-04-29 | -$14.00M derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2024-12-31 | $9.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | $9.80M derived: sum of 2 quarters · filed 2026-02-06 | $24.30M derived: sum of 3 quarters · filed 2026-02-06 | $17.50M 10-K · filed 2026-02-06 | ||||
| 2024-09-30 | $300.00K 10-Q · filed 2025-10-30 | $14.80M derived: sum of 2 quarters · filed 2025-10-30 | $8.00M 10-Q · filed 2024-10-30 | $13.60M derived: sum of 4 quarters · filed 2026-02-06 | ||||
| 2024-06-30 | $14.50M 10-Q · filed 2025-07-31 | $7.70M 10-Q · filed 2024-08-01 | $13.30M derived: sum of 3 quarters · filed 2026-02-06 | $26.80M derived: sum of 4 quarters · filed 2026-02-06 | ||||
| 2024-03-31 | -$6.80M 10-Q · filed 2025-05-01 | -$1.20M derived: sum of 2 quarters · filed 2026-02-06 | $12.30M derived: sum of 3 quarters · filed 2026-02-06 | $11.50M derived: sum of 4 quarters · filed 2026-02-06 | ||||
| 2023-12-31 | $5.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | $19.10M derived: sum of 2 quarters · filed 2026-02-06 | $18.30M derived: sum of 3 quarters · filed 2026-02-06 | $11.20M 10-K · filed 2026-02-06 | ||||
| 2023-09-30 | $13.50M 10-Q · filed 2024-10-30 | $12.70M derived: sum of 2 quarters · filed 2024-10-30 | $5.60M 10-Q · filed 2024-10-30 | $4.30M derived: sum of 4 quarters · filed 2025-02-12 | ||||
| 2023-06-30 | -$800.00K 10-Q · filed 2024-08-01 | -$7.90M 10-Q · filed 2024-08-01 | -$9.20M derived: sum of 3 quarters · filed 2025-02-12 | -$62.40M derived: sum of 4 quarters · filed 2025-02-12 | ||||
| 2023-03-31 | -$7.10M 10-Q · filed 2024-04-24 | -$8.40M derived: sum of 2 quarters · filed 2025-02-12 | -$61.60M derived: sum of 3 quarters · filed 2025-02-12 | -$56.80M derived: sum of 4 quarters · filed 2025-02-12 | ||||
| 2022-12-31 | -$1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12 | -$54.50M derived: sum of 2 quarters · filed 2025-02-12 | -$49.70M derived: sum of 3 quarters · filed 2025-02-12 | -$58.20M 10-K · filed 2025-02-12 | ||||
| 2022-09-30 | -$53.20M 10-Q · filed 2023-11-08 | -$48.40M derived: sum of 2 quarters · filed 2023-11-08 | -$56.90M 10-Q · filed 2023-11-08 | -$27.00M derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2022-06-30 | $4.80M 10-Q · filed 2023-07-25 | -$3.70M 10-Q · filed 2023-07-25 | $26.20M derived: sum of 3 quarters · filed 2024-02-14 | $61.40M derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2022-03-31 | -$8.50M 10-Q · filed 2023-04-25 | $21.40M derived: sum of 2 quarters · filed 2024-02-14 | $56.60M derived: sum of 3 quarters · filed 2024-02-14 | $59.00M derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2021-12-31 | $29.90M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $65.10M derived: sum of 2 quarters · filed 2024-02-14 | $67.50M derived: sum of 3 quarters · filed 2024-02-14 | $192.90M 10-K · filed 2024-02-14 | ||||
| 2021-09-30 | $35.20M 10-Q · filed 2022-10-25 | $37.60M derived: sum of 2 quarters · filed 2022-10-25 | $163.00M 10-Q · filed 2022-10-25 | $89.60M derived: sum of 4 quarters · filed 2023-02-15 | ||||
| 2021-06-30 | $2.40M 10-Q · filed 2022-07-20 | $127.80M 10-Q · filed 2022-07-20 | $54.40M derived: sum of 3 quarters · filed 2023-02-15 | $9.00M derived: sum of 4 quarters · filed 2023-02-15 | ||||
| 2021-03-31 | $125.40M 10-Q · filed 2022-05-03 | $52.00M derived: sum of 2 quarters · filed 2023-02-15 | $6.60M derived: sum of 3 quarters · filed 2023-02-15 | -$24.00M derived: sum of 4 quarters · filed 2023-02-15 | ||||
| 2020-12-31 | -$73.40M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-15 | -$118.80M derived: sum of 2 quarters · filed 2023-02-15 | -$149.40M derived: sum of 3 quarters · filed 2023-02-15 | -$162.80M 10-K · filed 2023-02-15 | ||||
| 2020-09-30 | -$45.40M 10-Q · filed 2021-10-20 | -$76.00M derived: sum of 2 quarters · filed 2021-10-20 | -$89.40M 10-Q · filed 2021-10-20 | -$132.40M derived: sum of 4 quarters · filed 2022-02-03 | ||||
| 2020-06-30 | -$30.60M 10-Q · filed 2021-07-22 | -$44.00M 10-Q · filed 2021-07-22 | -$87.00M derived: sum of 3 quarters · filed 2022-02-03 | $73.60M derived: sum of 4 quarters · filed 2022-02-03 | ||||
| 2020-03-31 | -$13.50M 10-Q · filed 2021-04-22 | -$56.40M derived: sum of 2 quarters · filed 2022-02-03 | $104.20M derived: sum of 3 quarters · filed 2022-02-03 | $70.70M derived: sum of 4 quarters · filed 2022-02-03 | ||||
| 2019-12-31 | -$42.90M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-03 | $117.70M derived: sum of 2 quarters · filed 2022-02-03 | $84.20M derived: sum of 3 quarters · filed 2022-02-03 | $104.80M 10-K · filed 2022-02-03 | ||||
| 2019-09-30 | $160.60M 10-Q · filed 2020-10-21 | $127.10M derived: sum of 2 quarters · filed 2020-10-21 | $147.70M 10-Q · filed 2020-10-21 | $155.50M derived: sum of 4 quarters · filed 2021-02-03 | ||||
| 2019-06-30 | -$33.50M 10-Q · filed 2020-07-22 | -$12.90M 10-Q · filed 2020-07-22 | -$5.10M derived: sum of 3 quarters · filed 2021-02-03 | $8.20M derived: sum of 4 quarters · filed 2021-02-03 | ||||
| 2019-03-31 | $20.60M 10-Q · filed 2020-04-23 | $28.40M derived: sum of 2 quarters · filed 2021-02-03 | $41.70M derived: sum of 3 quarters · filed 2021-02-03 | $83.50M derived: sum of 4 quarters · filed 2021-02-03 | ||||
| 2018-12-31 | $7.80M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-03 | $21.10M derived: sum of 2 quarters · filed 2021-02-03 | $62.90M derived: sum of 3 quarters · filed 2021-02-03 | $76.10M 10-K · filed 2021-02-03 | ||||
| 2018-09-30 | $13.30M 10-Q · filed 2019-10-22 | $55.10M derived: sum of 2 quarters · filed 2019-10-22 | $68.30M 10-Q · filed 2019-10-22 | $68.60M 10-Q · filed 2018-10-23 | $79.30M derived: sum of 4 quarters · filed 2020-02-06 | |||
| 2018-06-30 | $41.80M 10-Q · filed 2019-07-24 | $42.30M 10-Q · filed 2018-07-24 | $55.00M 10-Q · filed 2019-07-24 | $55.30M 10-Q · filed 2018-07-24 | $66.00M derived: sum of 3 quarters · filed 2020-02-06 | $75.40M derived: sum of 4 quarters · filed 2020-02-06 | ||
| 2018-03-31 | $13.20M 10-Q · filed 2019-04-24 | $13.00M 10-Q · filed 2018-04-24 | $24.20M derived: sum of 2 quarters · filed 2020-02-06 | $33.60M derived: sum of 3 quarters · filed 2020-02-06 | $20.00M derived: sum of 4 quarters · filed 2020-02-06 | |||
| 2017-12-31 | $11.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-06 | $20.40M derived: sum of 2 quarters · filed 2020-02-06 | $6.80M derived: sum of 3 quarters · filed 2020-02-06 | $1.50M 10-K · filed 2020-02-06 | -$1.50M 10-K · filed 2018-02-01 | |||
| 2017-09-30 | $9.40M 10-Q · filed 2018-10-23 | -$4.20M derived: sum of 2 quarters · filed 2018-10-23 | -$9.50M 10-Q · filed 2018-10-23 | -$28.40M derived: sum of 4 quarters · filed 2019-02-06 | ||||
| 2017-06-30 | -$13.60M 10-Q · filed 2018-07-24 | -$18.90M 10-Q · filed 2018-07-24 | -$37.80M derived: sum of 3 quarters · filed 2019-02-06 | -$55.90M derived: sum of 4 quarters · filed 2019-02-06 | ||||
| 2017-03-31 | -$5.30M 10-Q · filed 2018-04-24 | -$24.20M derived: sum of 2 quarters · filed 2019-02-06 | -$42.30M derived: sum of 3 quarters · filed 2019-02-06 | -$65.80M derived: sum of 4 quarters · filed 2019-02-06 | ||||
| 2016-12-31 | -$18.90M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-06 | -$37.00M derived: sum of 2 quarters · filed 2019-02-06 | -$60.50M derived: sum of 3 quarters · filed 2019-02-06 | -$95.80M 10-K · filed 2019-02-06 | $95.80M 10-K · filed 2017-02-02 | |||
| 2016-09-30 | -$18.10M 10-Q · filed 2017-10-24 | -$41.60M derived: sum of 2 quarters · filed 2017-10-24 | -$76.90M 10-Q · filed 2017-10-24 | $185.50M derived: sum of 4 quarters · filed 2018-02-01 | ||||
| 2016-06-30 | -$23.50M 10-Q · filed 2017-07-25 | -$58.80M 10-Q · filed 2017-07-25 | $203.60M derived: sum of 3 quarters · filed 2018-02-01 | $147.20M derived: sum of 4 quarters · filed 2018-02-01 | ||||
| 2016-03-31 | -$35.30M 10-Q · filed 2017-04-25 | $227.10M derived: sum of 2 quarters · filed 2018-02-01 | $170.70M derived: sum of 3 quarters · filed 2018-02-01 | $140.20M derived: sum of 4 quarters · filed 2018-02-01 | ||||
| 2015-12-31 | $262.40M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-01 | $206.00M derived: sum of 2 quarters · filed 2018-02-01 | $175.50M derived: sum of 3 quarters · filed 2018-02-01 | $164.50M 10-K · filed 2018-02-01 | ||||
| 2015-09-30 | -$56.40M 10-Q · filed 2016-10-26 | -$56.39M 10-Q · filed 2015-10-21 | -$86.90M derived: sum of 2 quarters · filed 2016-10-26 | -$97.90M 10-Q · filed 2016-10-26 | -$97.93M 10-Q · filed 2015-10-21 | -$55.96M derived: sum of 4 quarters · filed 2017-02-02 | ||
| 2015-06-30 | -$30.50M 10-Q · filed 2016-07-21 | -$30.49M 10-Q · filed 2015-07-24 | -$41.50M 10-Q · filed 2016-07-21 | -$41.54M 10-Q · filed 2015-07-24 | $442.00K derived: sum of 3 quarters · filed 2017-02-02 | -$10.87M derived: sum of 4 quarters · filed 2017-02-02 | ||
| 2015-03-31 | -$11.10M 10-Q · filed 2016-04-21 | -$11.05M 10-Q · filed 2015-04-24 | $30.94M derived: sum of 2 quarters · filed 2017-02-02 | $19.63M derived: sum of 3 quarters · filed 2017-02-02 | $15.31M derived: sum of 4 quarters · filed 2017-02-02 | |||
| 2014-12-31 | $42.04M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-02 | $30.73M derived: sum of 2 quarters · filed 2017-02-02 | $26.41M derived: sum of 3 quarters · filed 2017-02-02 | $31.80M 10-K · filed 2017-02-02 | $31.74M 10-K · filed 2015-02-04 | |||
| 2014-09-30 | -$11.31M 10-Q · filed 2015-10-21 | -$15.63M derived: sum of 2 quarters · filed 2015-10-21 | -$10.24M 10-Q · filed 2015-10-21 | -$63.83M derived: sum of 4 quarters · filed 2016-02-03 | ||||
| 2014-06-30 | -$4.32M 10-Q · filed 2015-07-24 | $1.07M 10-Q · filed 2015-07-24 | -$52.52M derived: sum of 3 quarters · filed 2016-02-03 | -$26.70M derived: sum of 4 quarters · filed 2016-02-03 | ||||
| 2014-03-31 | $5.39M 10-Q · filed 2015-04-24 | -$48.20M derived: sum of 2 quarters · filed 2016-02-03 | -$22.38M derived: sum of 3 quarters · filed 2016-02-03 | -$9.54M derived: sum of 4 quarters · filed 2016-02-03 | ||||
| 2013-12-31 | -$53.59M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-03 | -$27.77M derived: sum of 2 quarters · filed 2016-02-03 | -$14.93M derived: sum of 3 quarters · filed 2016-02-03 | -$27.60M 10-K · filed 2016-02-03 | $27.56M 10-K · filed 2014-02-06 | |||
| 2013-09-30 | $25.82M 10-Q · filed 2014-10-22 | $38.66M derived: sum of 2 quarters · filed 2014-10-22 | $25.99M 10-Q · filed 2014-10-22 | $79.21M derived: sum of 4 quarters · filed 2015-02-04 | ||||
| 2013-06-30 | $12.84M 10-Q · filed 2014-07-23 | $169.00K 10-Q · filed 2014-07-23 | $53.39M derived: sum of 3 quarters · filed 2015-02-04 | $52.83M derived: sum of 4 quarters · filed 2015-02-04 | ||||
| 2013-03-31 | -$12.67M 10-Q · filed 2014-04-23 | $40.55M derived: sum of 2 quarters · filed 2015-02-04 | $39.99M derived: sum of 3 quarters · filed 2015-02-04 | $7.14M derived: sum of 4 quarters · filed 2015-02-04 | ||||
| 2012-12-31 | $53.22M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-04 | $52.66M derived: sum of 2 quarters · filed 2015-02-04 | $19.81M derived: sum of 3 quarters · filed 2015-02-04 | $28.70M 10-K · filed 2015-02-04 | -$28.70M 10-K · filed 2013-02-05 | |||
| 2012-09-30 | -$560.00K 10-Q · filed 2013-10-28 | -$33.41M derived: sum of 2 quarters · filed 2013-10-28 | -$24.52M 10-Q · filed 2013-10-28 | -$58.60M derived: sum of 4 quarters · filed 2014-02-06 | ||||
| 2012-06-30 | -$32.85M 10-Q · filed 2013-07-25 | -$23.96M 10-Q · filed 2013-07-25 | -$58.04M derived: sum of 3 quarters · filed 2014-02-06 | -$76.99M derived: sum of 4 quarters · filed 2014-02-06 | ||||
| 2012-03-31 | $8.89M 10-Q · filed 2013-04-25 | -$25.19M derived: sum of 2 quarters · filed 2014-02-06 | -$44.14M derived: sum of 3 quarters · filed 2014-02-06 | -$14.52M derived: sum of 4 quarters · filed 2014-02-06 | ||||
| 2011-12-31 | -$34.08M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-06 | -$53.03M derived: sum of 2 quarters · filed 2014-02-06 | -$23.41M derived: sum of 3 quarters · filed 2014-02-06 | -$22.00K 10-K · filed 2014-02-06 | ||||
| 2011-09-30 | -$18.95M 10-Q · filed 2012-10-25 | $10.68M derived: sum of 2 quarters · filed 2012-10-25 | $34.06M 10-Q · filed 2012-10-25 | |||||
| 2011-06-30 | $29.62M 10-Q · filed 2012-07-24 | $53.01M 10-Q · filed 2012-07-24 | ||||||
| 2010-12-31 | -$74.35M 10-K · filed 2013-02-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |